QTRXNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

Quanterix Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$2.77−0.10 (-3.48%)

Close on Oct 19, 2026

Market cap: $130.65M
P/E (TTM): –
Dividend yield: –

Dividends

Quanterix has not reported a dividend

No dividend per share appears in Quanterix's annual filings since fiscal 2015.

Where these numbers come from

Parsed from the XBRL in Quanterix's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is QTRX.

Revenue growth22.0% · median 2.0%

Gross margin42.7% · median 53.2%

Operating margin-99.6% · median -21.6%

Net margin-80.2% · median -34.6%

Company	Revenue	Growth
TXG	$616.91M	-4.3%
CTKB	$206.71M	+5.4%
PACB	$159.27M	+2.0%
QTRX	$153.41M	+22.0%
HBIO	$87.81M	-1.1%
MASS	$60.84M	+13.4%

Company

Next earnings (est.): Nov 9, 2026, after close
Exchange: Nasdaq
Industry: Laboratory Analytical Instruments
Fiscal year ends: December 31
Employees: 450
Held by institutions: 68.1%
Auditor: KPMG LLP
SEC CIK: 1503274

Advertisement
300 × 250